What the research shows about inflammation reduction with GLP-1 medications Emerging studies suggest that GLP-1 medications may reduce these inflammatory markers: In several lab and animal studies modeling neurodegenerative diseases, activating the GLP-1 receptor in the brain consistently reduced inflammation and promoted neuroprotection
Contact your healthcare provider for fever above 100.4F, severe or persistent vomiting lasting more than 24-48 hours, signs of dehydration (decreased urine output, severe dizziness), severe abdominal pain, or respiratory symptoms, as these may indicate infection or complications requiring evaluation
In the current study, we found a novel mechanism by which GSTP1 protects human breast cancer cells from adriamycin (ADR)-induced cell death and contributes to the drug resistance
Cell Rep (2013) 3(4):112839.10.1016/j.celrep.2013.02.031 143 VasuSMoffettRCMcClenaghanNHFlattPR
Experimental models of traumatic brain injury: Do we really need to build a better mousetrap